Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer, Roche, Novartis lead the way for Big Pharma in Japan
Fierce Pharma
Friday, September 30, 2011 - 12:03pm
tags:
Japan, Pfizer, Roche, Novartis
Pharmasset Shares Surge on New Hep C Data
TheStreet.com
Friday, September 30, 2011 - 12:02pm
tags:
Pharmasset, hepatitis C, PSI-7977
Investors Guide to the New PDUFA
Motley Fool
Friday, September 30, 2011 - 11:16am
tags:
PDUFA, investors
ViroPharma pays Intellect Neurosciences $6.5 million for drug molecule rights
Yahoo/AP
Friday, September 30, 2011 - 11:10am
tags:
ViroPharma, Intellect Neurosciences, Friedreich's Ataxia, OX1
Array says potential lung cancer treatment misses statistical significance in mid-stage trial
Yahoo/AP
Friday, September 30, 2011 - 11:09am
tags:
Array, lung cancer, selumetinib, AstraZeneca
[video] The Next Big Thing In Biotech: Hep C Drugs
TheStreet.com
Friday, September 30, 2011 - 11:07am
tags:
hepatitis C, Inhibitex, Vertex, Indenix, Pharmasset
Add-on depression meds a bright spot in eroding market
Fierce Pharma
Friday, September 30, 2011 - 11:01am
tags:
antidepressants, Eli Lilly, Forest Labs, Pfizer
Cubist plans late-stage studies of diarrhea drug
Yahoo/AP
Friday, September 30, 2011 - 11:00am
tags:
Cubist, diarrhea, CB-183, 315, Clostridium Difficile
Cephalon gets Provigil, Nuvigil marketing subpoena
Yahoo/AP
Friday, September 30, 2011 - 10:56am
tags:
Cephalon, Provigil, NUVIGIL, subpoena, Teva Pharmaceuticals
Antares Scores Key Patent Possibly Linked To TEVA's Copaxone
Seeking Alpha
Friday, September 30, 2011 - 10:55am
tags:
Antares, patents, Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis
Torrent Pharma Gets FDA Tentative Approval for Memantine Pill
Bloomberg
Friday, September 30, 2011 - 10:54am
tags:
Torrent Pharmaceuticals, FDA, memantine, generics, Namenda, Forest Labs, Alzheimer's disease
Axis-Shield Possible Bidder Backs Away as Alere Raises Stake
Bloomberg
Friday, September 30, 2011 - 10:52am
tags:
Axis-Shield, M&A, Alere, diagnostics
Valeant Pharma Offer Tops Paladin's
Yahoo/Zacks.com
Friday, September 30, 2011 - 9:29am
tags:
Valeant Pharmaceuticals, Paladin, Cephalon, JNJ, Dermik, Sanofi
AstraZeneca settles Seroquel patent litigation
Marketwatch
Friday, September 30, 2011 - 9:27am
tags:
Seroquel, AstraZeneca, patents, Handa, Seroquel XR
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Forbes
Friday, September 30, 2011 - 9:26am
tags:
rivaroxaban, JNJ, Xarelto, acute coronary syndrome, Bayer
Are HIV Drugmakers Doomed?
Motley Fool
Friday, September 30, 2011 - 9:25am
tags:
HIV, Pfizer, Merck, JNJ, Bristol-Myers Squibb, Sangamo BioSciences, Gilead, Abbott Laboratories
Proximagen polishes its CNS rep with $16M Lundbeck deal
Fierce Biotech
Thursday, September 29, 2011 - 11:27am
tags:
Proximagen, Lundbeck, CNS
Narcolepsy Drug Wakes Up Pharmaceutical Stock
Forbes
Thursday, September 29, 2011 - 11:15am
tags:
narcolepsy, Jazz Pharmaceuticals, Xyrem
Pharma R&D and Payers Need to Talk, Yesterday
PharmExec
Thursday, September 29, 2011 - 9:10am
tags:
R&D, drug development
Biotech Investors Bow Out as Hurdles Grow
Bloomberg
Thursday, September 29, 2011 - 9:06am
tags:
investors, Human Genome Sciences, Savient, biotech, Dendreon, Vertex, Acorda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.